Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis

Alemtuzumab is a highly efficacious therapy used in the treatment of multiple sclerosis (MS), but uncoupling of T and B cell repopulation during immune reconstitution associates with an increasing range of secondary B cell-mediated autoimmune complications. A 34-year-old woman developed Graves’ dise...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMJ Case Rep
Prif Awduron: McCaughan, Georgia, Massey, Jennifer, Sutton, Ian, Curnow, Jennifer
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2017
Pynciau:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728240/
https://ncbi.nlm.nih.gov/pubmed/29212866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-223016
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg